--- title: "Allmed Medical: Net profit of 200 million yuan in the first half of 2025, a year-on-year increase of 6.87%" type: "News" locale: "en" url: "https://longbridge.com/en/news/254601934.md" description: "Allmed Medical announced that in the first half of 2025, operating revenue reached 1.676 billion yuan, a year-on-year increase of 5.99%. Net profit was 200 million yuan, a year-on-year increase of 6.87%. The company plans not to distribute cash dividends, not to issue bonus shares, and not to convert reserves into share capital" datetime: "2025-08-26T10:34:43.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/254601934.md) - [en](https://longbridge.com/en/news/254601934.md) - [zh-HK](https://longbridge.com/zh-HK/news/254601934.md) generator: "portal-rs" --- # Allmed Medical: Net profit of 200 million yuan in the first half of 2025, a year-on-year increase of 6.87% Allmed Medical announced that in the first half of 2025, operating revenue reached 1.676 billion yuan, a year-on-year increase of 5.99%. Net profit was 200 million yuan, a year-on-year increase of 6.87%. The company plans not to distribute cash dividends, not to issue bonus shares, and not to convert reserves into share capital ### Related Stocks - [002950.CN](https://longbridge.com/en/quote/002950.CN.md) ## Related News & Research - [HBC: Break-even operational EBITDA and premium pricing drove margin gains despite lower volumes](https://longbridge.com/en/news/296575295.md) - [08:31 ETTiger Group Offers Lab Equipment, Plastics Inventory and More from Grow Materials, LLC](https://longbridge.com/en/news/296491453.md) - [ASIA COFFEE-Vietnam price steady in thin trade, Indonesian premiums rise](https://longbridge.com/en/news/296470449.md) - [HiProMine Calls Crucial EGM to Revise Capital Plan and Decide on Future Operations](https://longbridge.com/en/news/296382728.md) - [Thales, Systematic partner to boost Danish air defense capabilities](https://longbridge.com/en/news/296363485.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**